SAN DIEGO (AP) _ Travere Therapeutics, Inc. (TVTX) on Thursday reported a loss of $35.6 million in its third quarter.

The San Diego-based company said it had a loss of 59 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 72 cents per share.

The drug developer posted revenue of $68.2 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $51.3 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TVTX at https://www.zacks.com/ap/TVTX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News